99 related articles for article (PubMed ID: 17257827)
1. Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer.
Murillo G; Matusiak D; Benya RV; Mehta RG
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):763-7. PubMed ID: 17257827
[TBL] [Abstract][Full Text] [Related]
2. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.
Munetsuna E; Kawanami R; Nishikawa M; Ikeda S; Nakabayashi S; Yasuda K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Mol Cell Endocrinol; 2014 Feb; 382(2):960-70. PubMed ID: 24291609
[TBL] [Abstract][Full Text] [Related]
4. Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon.
Matusiak D; Murillo G; Carroll RE; Mehta RG; Benya RV
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2370-6. PubMed ID: 16214919
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the anti-proliferative action of 25-hydroxy-19-nor-vitamin D(3) in human prostate cells.
Munetsuna E; Nakabayashi S; Kawanami R; Yasuda K; Ohta M; Arai MA; Kittaka A; Chen TC; Kamakura M; Ikushiro S; Sakaki T
J Mol Endocrinol; 2011 Oct; 47(2):209-18. PubMed ID: 21693624
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3.
Schwartz GG; Eads D; Rao A; Cramer SD; Willingham MC; Chen TC; Jamieson DP; Wang L; Burnstein KL; Holick MF; Koumenis C
Carcinogenesis; 2004 Jun; 25(6):1015-26. PubMed ID: 14742320
[TBL] [Abstract][Full Text] [Related]
7. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression.
Bareis P; Bises G; Bischof MG; Cross HS; Peterlik M
Biochem Biophys Res Commun; 2001 Jul; 285(4):1012-7. PubMed ID: 11467853
[TBL] [Abstract][Full Text] [Related]
8. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
9. Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo.
Verone-Boyle AR; Shoemaker S; Attwood K; Morrison CD; Makowski AJ; Battaglia S; Hershberger PA
Oncotarget; 2016 Jan; 7(1):995-1013. PubMed ID: 26654942
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of decreased Vitamin D 1alpha-hydroxylase activity in prostate cancer cells.
Ma JF; Nonn L; Campbell MJ; Hewison M; Feldman D; Peehl DM
Mol Cell Endocrinol; 2004 Jun; 221(1-2):67-74. PubMed ID: 15223133
[TBL] [Abstract][Full Text] [Related]
11. Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture.
Wierzbicka JM; Binek A; Ahrends T; Nowacka JD; Szydłowska A; Turczyk Ł; Wąsiewicz T; Wierzbicki PM; Sądej R; Tuckey RC; Slominski AT; Chybicki J; Adrych K; Kmieć Z; Żmijewski MA
Int J Oncol; 2015 Sep; 47(3):1084-96. PubMed ID: 26260259
[TBL] [Abstract][Full Text] [Related]
12. Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines.
Thompson L; Wang S; Tawfik O; Templeton K; Tancabelic J; Pinson D; Anderson HC; Keighley J; Garimella R
J Orthop Res; 2012 May; 30(5):831-44. PubMed ID: 22042758
[TBL] [Abstract][Full Text] [Related]
13. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand.
Lou YR; Molnár F; Peräkylä M; Qiao S; Kalueff AV; St-Arnaud R; Carlberg C; Tuohimaa P
J Steroid Biochem Mol Biol; 2010 Feb; 118(3):162-70. PubMed ID: 19944755
[TBL] [Abstract][Full Text] [Related]
14. Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α-hydroxylase.
Geng S; Zhou S; Glowacki J
J Bone Miner Res; 2011 May; 26(5):1145-53. PubMed ID: 21542014
[TBL] [Abstract][Full Text] [Related]
15. Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D₃ in human colon cancer cells.
Peng X; Tiwari N; Roy S; Yuan L; Murillo G; Mehta RR; Benya RV; Mehta RG
J Endocrinol; 2012 Feb; 212(2):207-15. PubMed ID: 22068926
[TBL] [Abstract][Full Text] [Related]
16. 25-hydroxyvitamin D 1alpha-hydroxylase: structure of the mouse gene, chromosomal assignment, and developmental expression.
Panda DK; Al Kawas S; Seldin MF; Hendy GN; Goltzman D
J Bone Miner Res; 2001 Jan; 16(1):46-56. PubMed ID: 11149489
[TBL] [Abstract][Full Text] [Related]
17. The vitamin D3 1alpha-hydroxylase gene and its regulation by active vitamin D3.
Takeyama K; Kato S
Biosci Biotechnol Biochem; 2011; 75(2):208-13. PubMed ID: 21307571
[TBL] [Abstract][Full Text] [Related]
18. 25-hydroxyvitamin D₃ and 1,25-dihydroxyvitamin D₃ promote the differentiation of human subcutaneous preadipocytes.
Nimitphong H; Holick MF; Fried SK; Lee MJ
PLoS One; 2012; 7(12):e52171. PubMed ID: 23272223
[TBL] [Abstract][Full Text] [Related]
19. The Vitamin D endocrine system of the gut--its possible role in colorectal cancer prevention.
Cross HS; Bises G; Lechner D; Manhardt T; Kállay E
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):121-8. PubMed ID: 16081282
[TBL] [Abstract][Full Text] [Related]
20. Without 1α-hydroxylation, the gene expression profile of 25(OH)D
Susa T; Iizuka M; Okinaga H; Tamamori-Adachi M; Okazaki T
Sci Rep; 2018 Jun; 8(1):9024. PubMed ID: 29899561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
